[1]
E. Žilinskas and A. Vaitkevičius, “Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe”, NS, vol. 27, no. Nr. 3 (97), pp. 182–200, Mar. 2024, doi: 10.29014/NS.2023.27.97.2.